Grand Pharmaceutical Group Limited ( (HK:0512) ) has provided an update.
Grand Pharmaceutical Group Limited announced the successful passing of all resolutions at its Annual General Meeting held on April 10, 2025. Key resolutions included the adoption of financial statements, declaration of a final dividend, re-election of directors, and granting of general mandates for share issuance and repurchase. The results reflect strong shareholder support and are expected to positively impact the company’s governance and operational strategies.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited is a company incorporated in Bermuda with limited liability, operating in the pharmaceutical industry. The company is listed on the Hong Kong Stock Exchange and focuses on the development and distribution of pharmaceutical products.
YTD Price Performance: 21.67%
Average Trading Volume: 8,519,114
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$20.73B
For an in-depth examination of 0512 stock, go to TipRanks’ Stock Analysis page.